SANDOZ DEFERASIROX (TYPE J)
SANDOZ DEFERASIROX (TYPE J)
Approved
DIN Number
02489902
Drug Class
Human
Market Date
Apr 19, 2021
Company
HC
Sandoz Canada, Inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02489902
AIG Number0151733005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
V03AC03 DEFERASIROX
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification64:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
DEFERASIROXActive
Strength: 180 MG
Monograph: DEFERASIROX